Drug intelligence / Profile preview

ursodeoxycholic acid + silymarin

Development stage
Unknown
Lead developer
MinaPharm
Modality
Small Molecules
Administration
Oral
01

Overview

**Ursodeoxycholic acid + silymarin** is a fixed-dose combination of two distinct hepatoprotective agents used for the management of liver diseases. Ursodeoxycholic acid, a hydrophilic bile acid, acts primarily by replacing cytotoxic bile acids, improving bile flow, and reducing cholesterol saturation, thereby aiding in the management of cholestatic liver disorders and certain gallstone conditions[2][5][8]. Silymarin, an extract from *Silybum marianum* (milk thistle), is a potent antioxidant and free radical scavenger that protects hepatocytes from oxidative stress and membrane injury, modulates inflammation, and inhibits fibrogenesis, thus supporting hepatic repair[3][6][9]. The combination is used in various acute and chronic liver disorders, including viral hepatitis, alcoholic liver disease, non-alcoholic fatty liver disease (NAFLD), cirrhosis, and primary biliary cholangitis[1][7][4][10].

Brand names
UdibonActimarinUrsokem PlusUlyses PlusUrdohep SLUdimarinUdiplusUrsodox PlusUdimarin ForteGemiuro Plus
Other names
silymarin + ursodeoxycholic acidsilymarin-ursodeoxycholic acidUDCA + silymarin
02

Targets

FXR (Farnesoid x-activated receptor)

Beyond the preview

Go deeper on ursodeoxycholic acid + silymarin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ursodeoxycholic acid + silymarin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call